Search results
A New Weapon Against Cancer: Checkpoint Inhibitors, A Double-Edged Sword
Forbes· 4 days agoThis article joins a growing series on mono cancer treatments, including novel immunotherapies such...
Roving blood cells that 'hunt and wipe out' cancer could stop disease spreading
The US Sun· 6 hours agoROVING white blood cells that hunt down cancer in different parts of the body could hold the key to...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 8 hours agoEDIT by two years. Per the collaboration, BMY and EDIT will research, develop, and commercialize...
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer - Barinthus...
Benzinga· 1 day agoBarinthus Biotherapeutics plc BRNS, formerly Vaccitech plc, a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates ...
Q1 2024 TG Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoWe recently entered into a partnership with Precision BioSciences to acquire worldwide license to Precision's either cell and allogeneic CD19 CAR T-cell ...
Allspring Global Investments Holdings LLC Acquires Shares of 39,059 Caribou Biosciences, Inc....
ETF DAILY NEWS· 5 days agoAllspring Global Investments Holdings LLC purchased a new stake in Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) in the 4th quarter, according to its most recent Form 13F filing with ...
Getting Under the Skin at May 11 Symposium on Melanoma
Newswise· 17 hours agoLOS ANGELES (May 2, 2024) -- The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, is teaming up with the AIM at Melanoma Foundation for the 14th year to host a free ...
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 6 hours agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Shares Bought by Golden State Equity Partners
ETF DAILY NEWS· 4 days agoGolden State Equity Partners raised its holdings in Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 21.0% in the 4th quarter, according to its most recent 13F filing with the Securities ...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 3 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
